Internal Medicine, Hematology · New York, NY
NPI
1417214974
Since 2012
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1470 Madison Ave
New York, NY, 10029
Phone (212) 241-6756
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
299 services
Medicare patients, 2024
107
Average age 74
Drug cost, 2024
$3.2M
252 prescriptions
Company payments, 2025
$27K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam S Kittai was code 99233 (hospital e&m - subsequent), 71 times for 18 patients. In total Adam S Kittai billed 299 services in 9 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 71 | 18 | $96.72 | $6,867 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 45 | 42 | $10.82 | $487 |
| 99215 Office E&M - Established | Facility | 40 | 15 | $124.58 | $4,983 |
| 99215 Office E&M - Established | Office | 36 | 30 | $74.04 | $2,665 |
| 99214 Office E&M - Established | Office | 30 | 30 | $49.53 | $1,486 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 25 | 12 | $14.30 | $358 |
| 99223 Hospital E&M - Initial | Facility | 18 | 16 | $144.66 | $2,604 |
| 99239 Hospital Discharge Management | Facility | 14 | 13 | $88.68 | $1,242 |
| 99205 Office E&M - New | Facility | 14 | 14 | $159.32 | $2,230 |
By year: 2022 $45K for 494 services; 2023 $45K for 489 services; 2024 $23K for 299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adam S Kittai prescribed most often to Medicare patients was Calquence (Acalabrutinib Maleate), with 139 prescriptions and refills. In total Adam S Kittai wrote 252 Medicare prescriptions that cost $3.2M.
Brand drugs: 216 claims; generic drugs: 36 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam S Kittai $27K ($27K in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $10K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $10K |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $7,146 |
| Genmab U.S., Inc. GMAB | 11 | $4,525 |
| AstraZeneca UK Limited AZN | 1 | $2,391 |
| Pfizer Inc. PFE | 5 | $1,870 |
| Genentech USA, Inc. ROG.SW | 6 | $589 |
| BeOne Medicines USA, Inc. ONC | 5 | $302 |
| Celgene Corporation BMY | 1 | $81.69 |
| Kite Pharma, Inc. GILD | 2 | $63.22 |
| Genentech, Inc. ROG.SW | 1 | $33.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.